We are live on ! Find out more
EI

EAM Investors Portfolio holdings

AUM $866M
1-Year Est. Return 377.14%
This Fund
S&P 500
This Quarter Est. Return
+113.09%
1 Year Est. Return
+377.14%
3 Year Est. Return
+5,228.32%
5 Year Est. Return
+49,813.17%
10 Year Est. Return
+19,957,666.26%
AUM
$452M
AUM Growth
+$130M
Cap. Flow
-$18.5M
Cap. Flow %
-4.08%
Top 10 Hldgs %
10.66%
Holding
352
New
147
Increased
15
Reduced
84
Closed
97

Top Buys

Rank Stock Value
1
AWH
Aspira Women's Health Inc. Common Stock
AWH
+$3.03M
2
OSPN icon
OneSpan
OSPN
+$2.96M
3
ATEX icon
Anterix
ATEX
+$2.79M
4
CALX icon
Calix
CALX
+$2.73M
5
GNMK
GenMark Diagnostics, Inc
GNMK
+$2.72M

Top Sells

Rank Stock Value
1
AXSM icon
Axsome Therapeutics
AXSM
+$3.54M
2
KPTI icon
Karyopharm Therapeutics
KPTI
+$3.44M
3
TDOC icon
Teladoc Health
TDOC
+$3.2M
4
KRYS icon
Krystal Biotech
KRYS
+$3M
5
PRNB
Principia Biopharma Inc. Common Stock
PRNB
+$2.95M

Sector Composition

Rank Sector Weight
1 Healthcare 30.95%
2 Technology 21.89%
3 Consumer Discretionary 16.2%
4 Industrials 10.05%
5 Consumer Staples 6.72%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AXSM icon
51
Axsome Therapeutics
AXSM
$10.9B
$2.41M 0.53%
29,293
-45,942
-61% -$3.54M
PTON icon
52
Peloton Interactive
PTON
$2.79B
$2.37M 0.52%
+41,022
New +$1.7M
GRWG icon
53
GrowGeneration
GRWG
$88.3M
$2.34M 0.52%
342,053
-146,182
-30% -$804K
VIVO
54
DELISTED
Meridian Bioscience Inc
VIVO
$2.3M 0.51%
+98,678
New +$1.43M
HALO icon
55
Halozyme
HALO
$9.76B
$2.28M 0.5%
+85,144
New +$1.92M
RPAY icon
56
Repay Holdings
RPAY
$343M
$2.28M 0.5%
92,654
– –
FORM icon
57
FormFactor
FORM
$9.38B
$2.27M 0.5%
77,542
-19,888
-20% -$490K
DT icon
58
Dynatrace
DT
$13.3B
$2.25M 0.5%
55,386
-4,877
-8% -$160K
TBIO
59
DELISTED
Translate Bio, Inc. Common Stock
TBIO
$2.23M 0.49%
+124,550
New +$1.88M
LSCC icon
60
Lattice Semiconductor
LSCC
$19.6B
$2.23M 0.49%
+78,555
New +$1.83M
DECK icon
61
Deckers Outdoor
DECK
$13.6B
$2.23M 0.49%
68,076
+8,280
+14% +$228K
STAA icon
62
STAAR Surgical
STAA
$1.21B
$2.22M 0.49%
+36,021
New +$1.47M
MODV
63
DELISTED
ModivCare
MODV
$2.21M 0.49%
+27,940
New +$1.89M
BL icon
64
BlackLine
BL
$1.92B
$2.2M 0.49%
26,539
-9,163
-26% -$612K
MRSN
65
DELISTED
Mersana Therapeutics
MRSN
$2.19M 0.48%
+3,750
New +$1.28M
IRTC icon
66
iRhythm Holdings
IRTC
$4.1B
$2.17M 0.48%
18,735
-6,647
-26% -$733K
DOMO icon
67
Domo
DOMO
$184M
$2.15M 0.48%
+66,799
New +$1.49M
BHVN
68
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$2.15M 0.47%
+29,385
New +$1.56M
BAND
69
Bandwidth Inc
BAND
$1.4B
$2.13M 0.47%
+16,795
New +$1.7M
IPHI
70
DELISTED
INPHI CORPORATION
IPHI
$2.12M 0.47%
18,051
-9,881
-35% -$1.04M
SAM icon
71
Boston Beer
SAM
$1.94B
$2.12M 0.47%
+3,942
New +$1.91M
RVP icon
72
Retractable Technologies
RVP
$19.8M
$2.11M 0.47%
+300,115
New +$1.39M
CALY
73
Callaway Golf Company
CALY
$3.43B
$2.1M 0.46%
+120,004
New +$1.67M
INFU icon
74
InfuSystem Holdings
INFU
$186M
$2.1M 0.46%
181,911
+70,367
+63% +$809K
GSHD icon
75
Goosehead Insurance
GSHD
$2.33B
$2.08M 0.46%
27,697
-2,893
-9% -$168K
1 2
3
4 5

Similar funds

RWM
RMG Wealth Management Platteville, Wisconsin $866M AUM 11.95% 1-Year Est. Return
MCM
Makena Capital Management Menlo Park, California $866M AUM 17.79% 1-Year Est. Return
HP
Havemeyer Place Greenwich, Connecticut $867M AUM
OMG
One Madison Group New York $866M AUM 33.81% 1-Year Est. Return
RB
Rodgers Brothers Harmony, Pennsylvania $866M AUM 30.05% 1-Year Est. Return
ICCFIA
IDG China Capital Fund III Associates Central Hong Kong, China $868M AUM 24.3% 1-Year Est. Return
WFAL
Wedbush Fund Advisers, LLC Pasadena, California $863M AUM
WCM
Wallace Capital Management Dallas, Texas $871M AUM 13.69% 1-Year Est. Return

EAM Investors's Q2 2020 Portfolio in Review

As of Q2 2020, EAM Investors held 352 positions worth $452M, up 40% from $322M the previous quarter. Its ten largest holdings account for 11% of the portfolio.

EAM Investors withdrew a net $18.5M in Q2 2020, closing 97 positions and reducing 84 holdings. Its most notable exit was Karyopharm Therapeutics, an estimated $3.44M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 31% of assets, down from 40% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, EAM Investors opened a new position in Aspira Women's Health Inc. Common Stock worth $2.61M.

  • EAM Investors's largest Q2 2020 buy was Aspira Women's Health Inc. Common Stock: 45,313 shares worth $2.61M.
  • EAM Investors added most to Purple Innovation in Q2 2020, an estimated $2.04M increase.
  • EAM Investors's biggest Q2 2020 reduction was Axsome Therapeutics, cutting an estimated $3.54M.
  • EAM Investors fully exited Karyopharm Therapeutics in Q2 2020, selling an estimated $3.44M.
  • EAM Investors's ten largest holdings make up 11% of its $452M portfolio in Q2 2020.
  • EAM Investors opened 147 new positions and closed 97 in Q2 2020.
  • EAM Investors's portfolio value rose 40% quarter-over-quarter to $452M.

Based on EAM Investors's 13F filing for Q2 2020, filed 13 Aug 2020.